440 related articles for article (PubMed ID: 28418925)
1. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
Tae N; Lee S; Kim O; Park J; Na S; Lee JH
Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
[TBL] [Abstract][Full Text] [Related]
2. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.
Sawamiphak S; Seidel S; Essmann CL; Wilkinson GA; Pitulescu ME; Acker T; Acker-Palmer A
Nature; 2010 May; 465(7297):487-91. PubMed ID: 20445540
[TBL] [Abstract][Full Text] [Related]
3. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
Pitulescu ME; Adams RH
Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636
[TBL] [Abstract][Full Text] [Related]
4. Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis.
Sun J; Huang W; Yang SF; Zhang XP; Yu Q; Zhang ZQ; Yao J; Li KR; Jiang Q; Cao C
Theranostics; 2018; 8(17):4695-4709. PubMed ID: 30279732
[TBL] [Abstract][Full Text] [Related]
5. The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.
Herkenne S; Paques C; Nivelles O; Lion M; Bajou K; Pollenus T; Fontaine M; Carmeliet P; Martial JA; Nguyen NQ; Struman I
Sci Signal; 2015 Nov; 8(403):ra117. PubMed ID: 26577922
[TBL] [Abstract][Full Text] [Related]
6. Ephrin-B1 and ephrin-B2 mediate EphB-dependent presynaptic development via syntenin-1.
McClelland AC; Sheffler-Collins SI; Kayser MS; Dalva MB
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20487-92. PubMed ID: 19915143
[TBL] [Abstract][Full Text] [Related]
7. Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis.
Bruns AF; Herbert SP; Odell AF; Jopling HM; Hooper NM; Zachary IC; Walker JH; Ponnambalam S
Traffic; 2010 Jan; 11(1):161-74. PubMed ID: 19883397
[TBL] [Abstract][Full Text] [Related]
8. BET Bromodomain Suppression Inhibits VEGF-induced Angiogenesis and Vascular Permeability by Blocking VEGFR2-mediated Activation of PAK1 and eNOS.
Huang M; Qiu Q; Xiao Y; Zeng S; Zhan M; Shi M; Zou Y; Ye Y; Liang L; Yang X; Xu H
Sci Rep; 2016 Apr; 6():23770. PubMed ID: 27044328
[TBL] [Abstract][Full Text] [Related]
9. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
10. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
11. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
Groppa E; Brkic S; Uccelli A; Wirth G; Korpisalo-Pirinen P; Filippova M; Dasen B; Sacchi V; Muraro MG; Trani M; Reginato S; Gianni-Barrera R; Ylä-Herttuala S; Banfi A
EMBO Rep; 2018 May; 19(5):. PubMed ID: 29643120
[TBL] [Abstract][Full Text] [Related]
12. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
14. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
[TBL] [Abstract][Full Text] [Related]
15. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
16. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
17. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
Chiodelli P; Rezzola S; Urbinati C; Federici Signori F; Monti E; Ronca R; Presta M; Rusnati M
Oncogene; 2017 Nov; 36(47):6531-6541. PubMed ID: 28783175
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
Pan R; Dai Y; Gao XH; Lu D; Xia YF
Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
[TBL] [Abstract][Full Text] [Related]
19. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
20. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
